S&P 500
(-0.05%) 5 466.53 points
Dow Jones
(-0.41%) 38 951 points
Nasdaq
(0.31%) 17 773 points
Oil
(0.25%) $81.03
Gas
(-3.23%) $2.67
Gold
(-0.91%) $2 309.70
Silver
(-0.39%) $28.76
Platinum
(1.44%) $1 000.60
USD/EUR
(0.30%) $0.936
USD/NOK
(0.81%) $10.69
USD/GBP
(0.34%) $0.791
USD/RUB
(-0.27%) $87.25

リアルタイムの更新: eFFECTOR Therapeutics, [EFTRW]

取引所: NASDAQ セクター: Healthcare 産業: Biotechnology
最終更新日時26 6月 2024 @ 22:52

-74.07% $ 0.000700

Live Chart Being Loaded With Signals

Commentary (26 6月 2024 @ 22:52):
Our systems believe the stock currently is undervalued by 0.97% compare to its pairs and should correct upwards.

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer...

Stats
本日の出来高 81 202
平均出来高 0
時価総額 345 164
EPS $-2.16 ( Q1 | 2024-05-09 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 24.32
ATR14 $0.00100 (142.86%)
AADI -0.59%
ABCL 2.38%
ABCM 0.04%
ABEO -2.84%
ABIO -0.42%
ABOS -1.17%
ABSI -1.02%
ABUS -2.46%
ABVX -1.58%
ACAD -1.28%
ACER -17.95%
ACET -2.03%
ACGN 1.29%
ACHL -4.15%
ACHV -0.22%
ACIU -1.03%
ACLX -0.73%
ACRV -1.34%
ACST -1.95%
ACXP 0.36%
ADAG -3.08%
ADAP -2.63%
ADGI 0.87%
ADIL 0.88%
ADMA -1.77%
ADPT 0.59%
ADTX -4.17%
ADVM 0.29%
ADXN -1.60%
AEON -1.11%
AEZS -3.51%
AFMD -3.85%
AGEN -1.15%
AGIO -0.54%
AGLE 6.66%
AGTC 0.00%
AIKI 0.85%
AIMDW -13.88%
AKBA -6.03%
AKRO -2.81%
AKTX 2.44%
AKUS 0.00%
ALBO 0.00%
ALDX -2.40%
ALEC -2.98%
ALGS -3.82%
ALKS -0.37%
ALLK -8.51%
ALLO -6.04%
ALLR -4.28%
ALNA 3.16%
ALNY 0.32%
ALPN 0.02%
ALPX 0.00%
ALRN -2.50%
ALT -8.63%
ALVR -2.59%
ALXN 0.00%
ALXO -8.37%
ALZN -2.05%
AMRN 1.61%
AMTI -3.13%
ANAB 0.00%
ANEB -4.55%
ANGN 0.00%
ANIX 0.40%
ANL -3.22%
ANNX -0.22%
ANPC -3.15%
APGE -1.07%
APGN 8.48%
APGNW 30.65%
APLM 1.46%
APLS -0.25%
APLT -4.39%
APM -1.26%
APOP 0.38%
APRE 2.29%
APTO 3.38%
APTX 3.17%
APVO 0.93%
ARAV -13.39%
ARCT -3.86%
ARDS -14.23%
ARDX -1.55%
ARGX -1.11%
ARNA 0.00%
ARPO -0.90%
ARQT -0.63%
ARTL -3.62%
ARTLW 0.00%
ARVN 3.23%
ARWR -3.29%
ASLN 1.15%
ASMB -1.23%
ASND -1.94%
ATAI -0.37%
ATHA 5.50%
ATHE 0.56%
ATHX -33.50%
ATNF 3.37%
ATOS 5.34%
ATRA 0.60%
ATXI -2.50%
ATXS 0.00%
AUPH -1.70%
AURA 0.22%
AUTL -0.29%
AVBP -1.89%
AVEO 0.00%
AVIR -0.15%
AVRO -1.41%
AVTE -3.10%
AVTX 0.05%
AVXL -2.59%
AXLA 0.00%
AXSM -2.63%
AYLA 0.00%
AZRX 2.07%
BBI 2.17%
BBIO 1.15%
BCAB 5.88%
BCDA -2.39%
BCDAW -41.77%
BCEL 0.00%
BCLI 3.09%
BCRX -0.99%
BCTX 2.95%
BCTXW -16.32%
BCYC 0.15%
BDRX -0.11%
BDTX -0.21%
BEAM -1.40%
BFRA -2.91%
BGNE -2.48%
BIOR -1.63%
BIVI -0.25%
BLCM -6.68%
BLI -5.88%
BLPH 0.00%
BLRX -0.45%
BLTE -1.09%
BLU 0.03%
BLUE 0.11%
BMEA -6.67%
BMRN -0.61%
BNOX -2.51%
BNTC -2.11%
BNTX -1.16%
BOLD -6.32%
BOLT -0.05%
BPMC -0.88%
BPTH 2.38%
BPTS -13.47%
BRNS 0.37%
BRTX -0.87%
BTAI 8.47%
BTTX 1.35%
BTX 0.05%
BVXV 0.74%
BXRX 7.39%
BYSI 0.47%
CABA -1.31%
CADL 2.12%
CALA 0.00%
CALC 0.00%
CALT -0.67%
CAPR -2.16%
CARA 8.21%
CARM 1.28%
CASI -3.98%
CATB -6.97%
CBAY 0.03%
CBIO -2.65%
CBLI -7.31%
CBUS -4.89%
CCCC -0.11%
CCXI 0.00%
CDAK 0.00%
CDIO -7.46%
CDIOW 24.00%
CDMO -2.11%
CDMOP 0.04%
CDT 0.00%
CDTTW -39.60%
CDTX -1.59%
CDXC -2.25%
CDXS 4.48%
CELC -3.47%
CELU -3.33%
CELUW 11.80%
CERC -1.68%
CERE -0.48%
CERO -6.00%
CEROW 0.60%
CFRX -27.95%
CGEM -3.64%
CGEN -1.66%
CGON -0.60%
CGTX -1.42%
CHMA -6.00%
CHRS -0.63%
CINC 0.00%
CING 2.44%
CINGW 34.95%
CKPT -2.90%
CLBS -16.75%
CLDX -2.68%
CLGN 1.20%
CLLS -4.14%
CLNN 1.61%
CLNNW 0.00%
CLRB 7.04%
CLSD -1.63%
CLSN -0.68%
CLVS 0.00%
CMMB 0.97%
CMND 3.23%
CMPI 0.00%
CMPX -3.30%
CMRA 0.00%
CMRAW 33.33%
CMRX -1.63%
CNCE 0.00%
CNSP -39.86%
CNST 0.00%
CNTA -0.45%
CNTB 2.26%
CNTX -4.11%
COCP -2.80%
COEPW 32.45%
COGT -2.52%
CORT 1.63%
COYA 3.20%
CPRX -0.33%
CRBP -1.25%
CRBU -3.98%
CRDF -1.55%
CRGX -0.74%
CRIS -0.38%
CRNX -3.47%
CRSP -0.24%
CRTX 2.63%
CRVO -1.90%
CRVS 2.80%
CSBR -1.59%
CTCX -11.35%
CTIC 0.06%
CTMX -2.90%
CTNM 1.33%
CTXR 5.95%
CUE 1.04%
CVAC 1.27%
CVKD 0.15%
CWBR 2.80%
CYAD -12.96%
CYCC 7.55%
CYCCP 5.49%
CYCN 12.21%
CYT -2.27%
CYTK -2.25%
CYTO -2.73%
DARE 1.69%
DAWN -1.49%
DBTX -0.81%
DBVT 0.91%
DFFN 10.28%
DICE 0.06%
DMAC 13.45%
DNLI -1.34%
DNTH -6.35%
DOMH -1.58%
DRMA -0.74%
DRMAW -1.25%
DRNA 0.00%
DRTS 4.63%
DRTSW 0.00%
DRUG -7.39%
DSGN -0.60%
DTIL 0.89%
DYAI 3.29%
EARS -1.77%
EDIT -2.62%
EDSA -1.00%
EFTR 2.54%
EFTRW -74.07%
EIGR -9.21%
ELAB -1.20%
ELDN 3.36%
ELEV -2.90%
ELOX 7.69%
ELTX -0.88%
ELVN -4.24%
ELYM -1.67%
ENGN 0.00%
ENGNW 0.12%
ENLV 2.17%
ENOB 1.79%
ENSC 7.12%
ENTA -0.35%
ENTO 1.66%
ENTX 1.60%
ENVB 2.39%
EPIX -0.08%
EPRX -2.97%
EPZM 0.00%
EQ 1.50%
EQRX -2.09%
EQRXW 0.00%
ERAS 0.96%
ERNA -0.96%
ERYP 1.30%
ESLA 2.69%
ESLAW 87.05%
ETNB -2.29%
ETON -0.30%
ETTX 0.00%
EVAX -1.78%
EVGN 0.58%
EVLO 0.00%
EWTX 0.40%
EXAI 0.19%
EXEL -0.36%
EYEG 0.04%
EYEN 3.32%
EYPT -0.42%
FATE -6.18%
FBIO 1.72%
FBIOP 0.32%
FBLG -9.00%
FBRX -6.12%
FDMT -2.82%
FENC -0.89%
FGEN -2.14%
FHTX 0.57%
FIXX 0.77%
FMTX 0.00%
FNCH 8.87%
FOLD -2.53%
FREQ 4.76%
FRLN 0.15%
FRTX 0.00%
FSTX 0.00%
FTRE -0.62%
FULC -3.68%
FUSN 0.00%
FWBI 4.59%
FWP 0.00%
GALT -7.62%
GANX -2.31%
GBIO -1.77%
GBT 0.01%
GDTC 0.50%
GERN -3.54%
GHRS -1.17%
GLMD 0.53%
GLPG -2.11%
GLSI 4.13%
GLTO -0.18%
GLUE -3.43%
GLYC -15.68%
GMAB -0.27%
GMDA -18.25%
GMTX 0.00%
GNCA -85.71%
GNFT -0.78%
GNLX 1.33%
GNPX 6.13%
GNTA 3.94%
GOSS -1.97%
GOVX -6.82%
GOVXW -49.04%
GPCR -4.28%
GRAY -10.80%
GRCL 0.05%
GRNA -0.03%
GRNAW 8.91%
GRPH -2.75%
GRTS 2.54%
GRTX 5.14%
GTHX 0.00%
GUTS -5.77%
GXGXW 41.67%
GYRE -0.50%
HALO -1.33%
HARP 0.09%
HCWB -7.81%
HEPA 2.80%
HGEN -84.62%
HILS 5.66%
HLVX -0.77%
HOOK 0.80%
HOTH -5.50%
HOWL -0.43%
HRMY -0.62%
HRTX 1.15%
HSTO 0.00%
HUMA 1.22%
HUMAW -0.01%
IBRX -5.16%
ICCC 0.22%
ICPT 0.21%
ICU 16.06%
ICUCW 20.20%
ICVX -0.91%
IDRA -23.04%
IDYA -1.85%
IFRX 0.00%
IGMS -0.15%
IKNA -0.30%
IKT 1.42%
IMAB -2.33%
IMCR -3.36%
IMGN 0.02%
IMGO 0.00%
IMMP 4.55%
IMMX -1.72%
IMNM -2.34%
IMNN 2.34%
IMPL -27.27%
IMRA 15.96%
IMRN 0.00%
IMRX 0.00%
IMTX -1.67%
IMTXW 6.00%
IMUX 2.78%
IMV 0.00%
IMVT -2.03%
INAB 1.10%
INBX 0.73%
INCY -1.17%
INDP 6.42%
INFI -52.38%
INKT 0.01%
INM -2.07%
INMB -0.28%
INO -4.28%
INSM -0.47%
INTS -1.47%
INVA -0.25%
INZY 0.68%
IOBT -5.51%
IONS -0.61%
IOVA -1.60%
IPA -0.27%
IPHA 5.58%
IPSC -0.78%
IRON -3.32%
ISEE 0.38%
ITOS -1.23%
ITRM 1.67%
IVA 6.96%
IVVD -1.24%
JAGX -0.53%
JANX -2.89%
JAZZ -0.96%
JNCE 0.00%
JSPR -7.65%
JSPRW 20.88%
JUNS 0.00%
JUNSW 0.00%
KA -0.68%
KALV -0.26%
KDNY 0.22%
KMPH -0.34%
KNSA -2.11%
KNTE -0.38%
KOD -5.14%
KPRX 1.38%
KPTI 0.00%
KRBP -10.00%
KRON 1.06%
KROS -1.66%
KRRO -3.50%
KRTX 0.03%
KRYS -1.06%
KTRA 13.00%
KTTA 8.16%
KTTAW 0.92%
KURA -1.85%
KYMR -2.63%
KYTX -6.19%
KZIA 4.11%
KZR -0.20%
LABP 0.57%
LBPH -1.82%
LBPS 0.00%
LBPSW 14.81%
LEGN 0.34%
LENZ -4.24%
LEXX 0.00%
LEXXW -14.63%
LGND -0.79%
LGNDV 0.00%
LGVN -7.98%
LIAN -8.28%
LIFE 2.70%
LIPO -11.13%
LIXT -3.77%
LIXTW 95.35%
LJPC -0.32%
LMNL 0.12%
LOGC 0.87%
LPCN -6.75%
LPTX -0.55%
LQDA -0.24%
LRMR -0.78%
LSTA -2.17%
LTRN 1.75%
LUMO -1.32%
LVTX -2.25%
LXEO -2.07%
LXRX -2.65%
LYEL -27.94%
LYRA -0.74%
MACK 0.10%
MBIO -8.94%
MBRX -0.71%
MCRB 6.66%
MDGL -2.49%
MDNA -13.16%
MDWD 0.21%
MDXG -2.14%
MEIP 0.24%
MESO -1.93%
MGNX -4.44%
MGTA -7.74%
MGTX -1.78%
MGX -0.13%
MIRM -0.91%
MIRO 0.59%
MIST 2.69%
MITO 0.00%
MLEC -5.13%
MLECW 2.31%
MLND -5.36%
MLTX -0.84%
MLYS -0.86%
MNKD -1.14%
MNMD 0.14%
MNOV 1.41%
MNPR -5.48%
MOLN -2.95%
MOR 1.37%
MORF -3.46%
MREO -2.86%
MRKR 4.50%
MRNA -4.73%
MRNS -3.31%
MRSN -2.14%
MRTX -0.17%
MRUS -0.12%
MRVI 0.36%
MTCR -1.29%
MTEM 4.46%
MTP -18.50%
MURA -0.93%
MYMD 2.70%
NAMS -0.20%
NAMSW 0.43%
NAUT 1.99%
NBRV 0.71%
NBSE -1.56%
NBTX 10.32%
NCNA 1.32%
NERV -2.53%
NEXI 2.60%
NGM -1.28%
NGNE -0.31%
NKGN 3.36%
NKGNW 8.00%
NKTR -2.34%
NKTX -3.43%
NLSP -1.71%
NLSPW 26.67%
NMRA 0.34%
NMTR -42.97%
NOVN -24.84%
NRBO 14.72%
NRIX 0.11%
NRSN -4.82%
NRSNW 0.00%
NRXP -8.93%
NRXPW 14.03%
NRXS -2.73%
NTBL 2.49%
NTEC -12.45%
NTHI 0.00%
NTLA -6.66%
NTRBW -31.07%
NUVL -1.10%
NVAX -3.65%
NVCT 0.07%
NVIV -34.28%
NXTC -3.77%
NYMX -0.05%
OABI 2.24%
OABIW -10.06%
OBIO -1.46%
OBSV 0.00%
OCEA 0.35%
OCGN 3.39%
OCS -1.02%
OCUL -4.04%
OCUP 2.61%
ODT -4.27%
OKYO 1.51%
OLMA -3.67%
OMER -1.54%
OMGA 5.00%
ONCO 8.69%
ONCR -3.08%
ONCS 31.87%
ONCT -1.87%
ONCY -0.99%
ONTX -0.47%
ONVO 0.99%
OPNT 0.00%
OPT 0.75%
ORGS -0.07%
ORIC -2.67%
ORMP 16.64%
ORPH 0.00%
ORTX 0.30%
OSMT -1.77%
OTIC -92.64%
OTLK -1.67%
OVID -2.86%
OYST 0.00%
PALI -3.25%
PASG 3.08%
PBLA 0.00%
PBM -4.00%
PBYI -0.34%
PCSA 1.83%
PCVX -0.36%
PDSB 4.43%
PEPG 3.28%
PGEN -2.10%
PHAR 1.51%
PHAS 0.00%
PHAT -2.23%
PHIO -4.96%
PHIOW 36.47%
PHVS -6.38%
PHXM -5.20%
PIRS 0.58%
PKBO 0.00%
PKBOW 999 900.00%
PLRX -0.78%
PLUR 4.35%
PMN -7.47%
PMVP -1.19%
PNT 0.16%
PPBT -4.26%
PRAX 2.65%
PRDS 0.93%
PRLD -3.40%
PROG -3.47%
PROK 0.45%
PRQR 1.82%
PRTA -3.08%
PRTC -0.08%
PRTG 1.95%
PRTK 1.83%
PRVB 0.00%
PSTI -2.91%
PSTV -2.32%
PSTX 0.00%
PTCT -1.00%
PTE -0.82%
PTGX -2.43%
PTIXW -5.10%
PULM 2.63%
PXMD 0.00%
PYPD 0.07%
PYXS 0.00%
QLGN 0.00%
QNCX 3.56%
QNRX 0.33%
QSI -11.89%
QSIAW -3.13%
QTTB -0.83%
QURE -1.35%
RAIN -1.63%
RANI 5.08%
RAPT -3.25%
RARE 1.76%
RCKT -3.53%
REGN -1.70%
RENB -3.42%
REPL -0.79%
RETA 0.02%
REUN -0.89%
REVB -5.16%
REVBU 3.46%
REVBW -18.13%
RGLS -4.44%
RGNX -3.25%
RIGL -1.13%
RLAY -4.75%
RLMD 0.67%
RLYB 1.01%
RNA -0.82%
RNAC -1.85%
RNAZ 1.92%
RNXT 4.84%
ROIV -0.92%
ROIVW 4.56%
RPHM 0.62%
RPRX 0.30%
RPTX -1.91%
RUBY 2.70%
RVLP -32.05%
RVMD -0.44%
RVMDW 5.10%
RVNC 1.70%
RVPH 0.00%
RVPHW 1.62%
RXDX 0.09%
RXRX -2.08%
RYTM -3.67%
RYZB 0.02%
RZLT 2.07%
SABS 0.00%
SABSW -11.81%
SAGE -0.73%
SANA -2.95%
SAVA -0.99%
SAVAW 0.00%
SBBP 1.52%
SBTX 1.03%
SCNI 7.09%
SCPH 0.38%
SCPS 0.00%
SEEL -4.09%
SEER 0.00%
SELB -8.00%
SESN 7.29%
SGEN -0.07%
SGMO 1.14%
SGMT 0.72%
SGTX -2.56%
SIOX 22.63%
SLDB -3.97%
SLGL 2.97%
SLN -3.73%
SLNO -2.16%
SLRX 7.29%
SLS -2.51%
SMMT 0.38%
SNDX -0.82%
SNGX 1.70%
SNPX -0.32%
SONN -0.82%
SPPI -0.49%
SPRB 0.93%
SPRC -1.98%
SPRO 0.23%
SRNE -25.00%
SRPT -0.60%
SRRA 0.00%
SRRK -4.58%
SRZN -2.45%
STAB 0.00%
STOK -2.80%
STRO -2.51%
STSA 0.00%
STTK -3.80%
SURF -0.93%
SVRA 3.42%
SWTX -0.36%
SYBX -2.58%
SYRS -0.75%
TALS -0.73%
TARA -5.26%
TARS -1.78%
TBPH 0.83%
TCBP 2.74%
TCDA 0.00%
TCON -3.38%
TCRR 0.00%
TCRT 5.75%
TCRX 3.23%
TECH -0.11%
TENX -1.27%
TERN -5.10%
TFFP -3.52%
TGTX -2.06%
THRX 0.12%
TIL 0.02%
TLC 0.00%
TLSA -2.07%
TNGX 0.43%
TNXP -2.41%
TNYA -4.73%
TPST 0.00%
TRDA -2.71%
TRVI -0.77%
TRVN 1.00%
TSHA -19.31%
TSVT -3.32%
TTNP -6.21%
TVTX -0.63%
TYRA -5.24%
UBX -0.48%
UNCY -3.80%
URGN -3.21%
UTHR 0.04%
VACC 11.36%
VALN -2.65%
VAXX 181.82%
VBIV 0.76%
VBLT -8.77%
VCEL -0.53%
VCNX 9.01%
VCYT -0.18%
VERA -2.58%
VERU -2.37%
VERV -1.91%
VIGL 4.30%
VINC 2.30%
VIR 1.30%
VIRI -3.16%
VIRX 3.24%
VKTX -0.65%
VLON -13.04%
VNDA -1.30%
VOR -2.01%
VRCA 1.85%
VRDN -4.39%
VRNA 0.60%
VRPX 0.20%
VRTX 1.01%
VSTM -3.75%
VTGN -0.75%
VTVT -6.43%
VTYX -2.09%
VXRT -0.43%
VYGR -2.05%
VYNE -4.62%
VYNT 7.78%
WINT -3.24%
WVE -4.16%
XBIO 1.15%
XBIT -1.04%
XCUR 6.49%
XENE -1.97%
XERS 2.14%
XFOR 1.98%
XLO 4.43%
XLRN 0.00%
XNCR -0.15%
XOMA -0.41%
XOMAO 0.36%
XOMAP -0.82%
XRTX -7.04%
YMAB -2.23%
ZGNX 0.00%
ZIOP -0.88%
ZLAB -2.85%
ZNTL -4.17%
ZSAN 0.00%
Insider Trading
Date Person Action Amount type
2023-11-27 Sr One Capital Management, Llc Sell 430 578 Common Stock
2023-11-27 Sr One Capital Management, Llc Sell 178 585 Common Stock
2023-11-15 Worland Stephen T Buy 5 979 Common Stock
2023-11-15 Byrnes Michael Buy 4 524 Common Stock
2023-09-09 Loewy Caroline M Buy 40 000 Stock Option (Right to Buy)
INSIDER POWER
28.90
Last 94 transactions
Buy: 4 047 347 | Sell: 1 063 888
相関 (AI algo v.1.1b): Undervalued: 0.97% $0.000707 paired level. (アルゴリズムは、最も相関の高い株式の変更をリアルタイムで追跡し、即時の更新を提供します)

eFFECTOR Therapeutics, 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

eFFECTOR Therapeutics, 財務諸表

Annual 2023
収益: $0
総利益: $-111 000 (0.00 %)
EPS: $-16.37
FY 2023
収益: $0
総利益: $-111 000 (0.00 %)
EPS: $-16.37
FY 2022
収益: $3.55M
総利益: $3.50M (98.51 %)
EPS: $-7.85
FY 2021
収益: $0.00
総利益: $0.00 (0.00 %)
EPS: $0

Financial Reports:

No articles found.

eFFECTOR Therapeutics, Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

eFFECTOR Therapeutics,

eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-small cell lung cancer. The company is also developing zotatifin, a small molecule designed to inhibit eukaryotic initiation factor 4A (eIF4E), which is in Phase 1/2 clinical trial to treat patients with solid tumors and in combination with fulvestrant and abemaciclib in a Phase 2a open-label expansion cohort to treat patients with ER+ breast cancer. eFFECTOR Therapeutics, Inc. has a research collaboration and license agreement with Pfizer Inc. to develop inhibitors of eIF4E. eFFECTOR Therapeutics, Inc. was incorporated in 2012 and is headquartered in Solana Beach, California.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。

Total Execution Time: 1.2419250011444 seconds
Number of API calls: 3
Number of DB calls: 9